Heritage Cannabis Holdings (CANN.C) closed its acquisition of Canadian-based recreational and medical cannabis company, Premium 5, today, according to a press release. Premium 5 products
On July 25, 2019 Heritage Cannabis (CANN.C) announced a vape-device deal with the $6.6 billion Cronos Group (CRON.T). Heritage will fill and package vaporizer devices
Heritage Cannabis (CANN.C), one of Canada’s fastest-growing vertically integrated marijuana providers, has just completed a bought deal offering of 32.66 million units of CANN shares.
On April 1, 2019, Heritage Cannabis (CANN.C) announced that its subsidiary CannaCure has received both its Standard Processing Licence and Medical Sales Licence from Health
On February 25, 2019, Heritage Cannabis (CANN.C) announced a significant expansion of its medical cannabis footprint, with the addition of BriteLife Sciences – a newly-formed 100%
In the past two days, Heritage Cannabis (CANN.C) has upgraded their facilities across Canada to accommodate in-house extraction. Heritage recently delivered the first two Vitalis Q90 systems
Heritage Cannabis Holdings (CANN.C) has appointed Erin Prohaska as the company’s new CFO. Prohaska brings extensive experience leading finance and operations teams, including recently serving as
Heritage Cannabis Holdings (CANN.C) announced the appointment of Canadian wine-making legend, Donald Ziraldo, to its board. The company also named interim CEO, Clint Sharples, as
Heritage Cannabis Holdings (CANN.C) put rubber to the road today when the Calgary-based company’s subsidiary, CannaCure, brought in the first cannabis harvest at its Fort
On October 15, 2018 Heritage Cannabis (CANN.C) announced that its acquisition target CannaCure has been granted a license to grow weed, pursuant to the Access
